GMED
Globus Medical
74.30$
+0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.8% | +3.5% | +12.8% | +12.1% | +10.2% | +0.5% | +21.4% | +6.8% | +53.3% | +60.6% | +16.7% | |
| – | +19.5% | +1.8% | +11.7% | +6.0% | +12.9% | +20.8% | +10.0% | +10.2% | +107.9% | +88.9% | -7.5% | |
| – | +13.4% | +4.1% | +13.1% | +14.0% | +9.4% | -5.6% | +25.8% | +5.6% | +34.4% | +45.4% | +33.5% | |
| – | +16.5% | +22.6% | -1.9% | +27.1% | +8.2% | +40.7% | +15.2% | -25.0% | +69.8% | +32.0% | +13.0% | |
| – | +14.0% | +3.8% | +20.6% | +16.3% | +13.9% | +0.0% | +15.1% | +5.9% | +48.9% | +52.5% | +20.1% | |
| – | +6.6% | +14.6% | +17.6% | +18.7% | +12.8% | +6.2% | +18.9% | -2.9% | +67.0% | +48.6% | +13.9% | |
| – | +24.5% | -10.5% | +5.0% | +4.6% | +1.6% | -35.2% | +54.3% | +32.6% | -41.6% | +24.7% | +189.1% | |
| – | +62.0% | +134.4% | +116.2% | +100.9% | +31.1% | -19.8% | -33.4% | +53.1% | +41.4% | -79.2% | – | |
| – | +24.6% | -9.0% | +8.0% | +11.0% | +0.7% | -33.7% | +43.3% | +34.7% | -31.9% | -27.0% | +405.2% | |
| – | +30.0% | -11.8% | +18.2% | -48.7% | +8.1% | -32.0% | +32.2% | +69.3% | -19.5% | -58.3% | +305.9% | |
| – | +21.9% | -7.5% | +2.9% | +45.8% | -0.8% | -34.1% | +45.9% | +27.5% | -35.4% | -16.2% | +422.3% | |
| – | +22.6% | -1.3% | +6.4% | +6.4% | +5.0% | -22.3% | +48.4% | +15.0% | +13.8% | +36.7% | +54.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.